← All trials
NCT03734692
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 28, 2019
- Primary completion
- Feb 20, 2021
- Completion date
- Nov 20, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 45
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of PittsburghLead sponsor
- MerckCollaborator
- University of PittsburghSponsor investigator
- University of PittsburghOverall official - principal investigator
- Hemispherx BiopharmaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.